For laboratory preparation, up to 5 mL of bacteriostatic water or another suitable research solvent may be added to reconstitute the blend into a clear multi-dose solution
In the small published human studies to date, BPC-157 was well tolerated, with no meaningful changes in cardiac, hepatic, renal, or metabolic markers
Read professional profile Dr Snieguole Geige Dentist and medical doctor with experience across healthcare, preventative medicine and patient centred clinical standards
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
It resulted in acne, palpitations, anxiety, uncontrollable movements, facial redness, headache, and insomnia
Barakat, J
